Patent · US Active

Wet granulation using a water sequestering agent

US8263122B2 · kind B2 · utility

2Cited by

9References

16Claims

0Family size

Assignee

Rigel Pharmaceuticals, Inc. · US

Inventors

Thomas Sun · Fremont, US
Ray J. Lo · San Leandro, US

Key dates

Filing date	Nov 6, 2008
Grant date	Sep 11, 2012
Priority date	—
Expiry date	Nov 24, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are tablets comprising hydrolytically stable formulations of (6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl phosphate disodium salt (Compound 1) prepared by a wet granulation process.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.